Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Apr 29;3(6):luaf091.
doi: 10.1210/jcemcr/luaf091. eCollection 2025 Jun.

Prolonged Adrenal Insufficiency After Failed Cryoablation and Osilodrostat for Cushing Syndrome in Nodular Adrenal Disease

Affiliations
Case Reports

Prolonged Adrenal Insufficiency After Failed Cryoablation and Osilodrostat for Cushing Syndrome in Nodular Adrenal Disease

Colleen Veloski et al. JCEM Case Rep. .

Abstract

Nodular adrenocortical disease is an entity more commonly recognized in recent years. We present a case of bilateral adrenal nodular disease in a young woman with ACTH-independent Cushing syndrome. She was treated with medical therapies at her preference to avoid adrenal insufficiency (AI) from surgery. She developed intolerance to medical therapy. Cryoablation of the right adrenal nodule was performed after adrenal vein sampling identified the right adrenal as the dominant source of cortisol. Cortisol levels were normal while on medical therapy after cryoablation but quickly became elevated after discontinuing medical therapy. The patient was then treated with osilodrostat and ultimately developed medication-induced AI that has persisted for more than 3 years. Due to the increased availability of new medications to treat Cushing syndrome, we present our experience to educate endocrinology audiences about the unexpected responses to medications. Using osilodrostat (off-label) in this patient led to prolonged primary AI after 4 months of use and now presumed permanent AI 36 months after discontinuation of treatment.

Keywords: Cushing syndrome; adrenal adenoma; adrenal insufficiency; adrenal nodule; osilodrostat.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Initial noncontrast computed tomography imaging of the patient from February 18, 2015, shows that the right adrenal gland nodule measured 1.9 × 2.0 cm, 30 HU; left adrenal gland nodule measured 2.4 × 1.6 cm, 15 HU. These were consistent with indeterminate bilateral adrenal nodules. White arrows show the right and left adrenal glands. Abbreviation: HU, Hounsfield units.
Figure 2.
Figure 2.
Contrast-enhanced computed tomography of imaging of the patient from October 7, 2020, before adrenal cryoablation without significant change from 2015 imaging. (A) Imaging of right adrenal gland; (B) imaging of left adrenal gland.
Figure 3.
Figure 3.
Contrast-enhanced computed tomography of imaging of the patient from December 8, 2020, after adrenal cryoablation (right October 7, 2020) with stable sizes from prior to cryoablation on the right adrenal gland. White arrows show the right and left adrenal glands. (A) Imaging of right adrenal gland; (B) imaging of left adrenal gland.
Figure 4.
Figure 4.
Noncontrast computed tomography imaging of the patient from March 30, 2022, shows that the right adrenal nodule measured 1.1 × 1.1 cm, 20 HU; left adrenal gland measured 2.0 × 1.4 cm (HU not available). White arrows show the right and left adrenal glands. Abbreviation: HU, Hounsfield units.

Similar articles

References

    1. Young WF Jr., du Plessis H, Thompson GB, et al. The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses. World J Surg. 2008;32(5):856‐862. - PubMed
    1. Acharya R, Dhir M, Bandi R, Yip L, Challinor S. Outcomes of adrenal venous sampling in patients with bilateral adrenal masses and ACTH-independent Cushing's syndrome. World J Surg. 2019;43(2):527‐533. - PubMed
    1. Johnson PC, Thompson SM, Adamo D, et al. Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with bilateral adrenal masses. Clin Endocrinol (Oxf). 2023;98(2):177‐189. - PubMed
    1. Pivonello R, Fleseriu M, Newell-Price J, et al. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. Lancet Diabetes Endocrinol. 2020;8(9):748‐761. - PubMed
    1. de Cremoux P, Rosenberg D, Goussard J, et al. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease. Endocr Relat Cancer. 2008;15(2):465‐474. - PubMed

Publication types

LinkOut - more resources